Combating Illicit Xylazine Act
Congress Proposes Classifying Xylazine as a Controlled Substance to Combat Illegal Drug Use
Stalled
No legislative action in over 90 days.
Legislative Progress
Key Points
- This bill would classify xylazine as a Schedule III controlled substance. Xylazine is a powerful tranquilizer used by veterinarians for animals like horses and cattle, but it is increasingly being mixed with illegal drugs like fentanyl, leading to severe health risks and deaths.
- Veterinarians and pharmacies would still be allowed to use and sell the drug for animal care, but they would have to follow stricter federal rules for recordkeeping and security. People who own or care for animals can still legally have the drug if a licensed vet prescribes it.
- The policy aims to stop the drug from being diverted to the illegal market. By making it a controlled substance, the government can use a special tracking system to see where the drug is going and catch people who are selling it for human use.
- If this becomes law, most recordkeeping rules would start within 60 days, while new requirements for labeling and packaging would take one year to begin. This gives businesses and doctors time to adjust to the new regulations.
- To prevent supply shortages for animal care, the bill says companies that already make xylazine do not have to spend money on expensive new security upgrades for their buildings. It also asks the government to study where illegal xylazine is coming from and if similar drugs are becoming a problem.
Impact Analysis
Personal Impact
Life & Work
The bill directs the U.S. Sentencing Commission to create penalties for xylazine-related offenses under the Controlled Substances Act. People caught manufacturing, distributing, or possessing xylazine illegally could face new federal criminal charges and prison time, adding a new category of drug offense to the criminal justice system.
Disabilities
Milestones
Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
The committee approved this bill and is sending it to the full chamber for a vote. This is a significant step — most bills never get this far.
Read twice and referred to the Committee on the Judiciary.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
Related News
4 articlesCongress reintroduces bipartisan xylazine bill
Bipartisan lawmakers have reintroduced the Combating Illicit Xylazine Act to categorize the drug as a Schedule III controlled substance. The bill includes protections for veterinarians to ensure they maintain access to the sedative for legitimate animal care while cracking down on illicit use.
Lawmakers Move to Restrict Xylazine Access
Congressional leaders introduced legislation to further restrict access to xylazine, known as 'tranq,' by reclassifying it as a Schedule III drug. The move follows DEA warnings that the drug is found in nearly 25% of seized fentanyl powder, causing severe health risks like necrotic skin ulcers.
How Congress can protect a vital animal drug while cracking down on illicit use
The American Veterinary Medical Association urges Congress to pass the Combating Illicit Xylazine Act to address the rise of 'tranq' in the drug supply. The legislation is framed as a balanced solution that empowers law enforcement while safeguarding the legitimate supply for livestock and pets.
Source Information
Document Type
Congressional Bill
Official Title
Combating Illicit Xylazine Act
Data Sources
Sponsor
Cosponsors
(34)Analysis generated by AI. Always verify with official sources.